9 results match your criteria: "University of Ottawa and University of Ottawa Heart Institute[Affiliation]"
J Nucl Cardiol
December 2024
Division of Cardiology, University of Ottawa and University of Ottawa Heart Institute, Ottawa, Canada.
Infect Dis Model
December 2024
Department of Civil and Environmental Engineering, Carleton University, Ottawa, ON K1S 5B6, Canada.
We consider state and parameter estimation for compartmental models having both time-varying and time-invariant parameters. In this manuscript, we first detail a general Bayesian computational framework as a continuation of our previous work. Subsequently, this framework is specifically tailored to the susceptible-infectious-removed (SIR) model which describes a basic mechanism for the spread of infectious diseases through a system of coupled nonlinear differential equations.
View Article and Find Full Text PDFInt J Stroke
January 2025
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Background: Early ischemic changes on baseline imaging are commonly evaluated for acute stroke decision-making and prognostication.
Aims: We assess the association of early ischemic changes on clinical outcomes and whether it differs between intravenous tenecteplase and Alteplase.
Methods: Data are from the phase 3, Alteplase compared to Tenecteplase (AcT) trial.
Math Biosci Eng
July 2023
Department of Civil and Environmental Engineering, Carleton University, Ottawa, Ontario, Canada.
A nonlinear partial differential equation (PDE) based compartmental model of COVID-19 provides a continuous trace of infection over space and time. Finer resolutions in the spatial discretization, the inclusion of additional model compartments and model stratifications based on clinically relevant categories contribute to an increase in the number of unknowns to the order of millions. We adopt a parallel scalable solver that permits faster solutions for these high fidelity models.
View Article and Find Full Text PDFNat Cardiovasc Res
February 2023
Department of Translational Medicine, The Hospital for Sick Children, Toronto, Ontario Canada.
Cardiac metabolism is deranged in heart failure, but underlying mechanisms remain unclear. Here, we show that lysine demethylase 8 (Kdm8) maintains an active mitochondrial gene network by repressing , thus preventing dilated cardiomyopathy leading to lethal heart failure. Deletion of in mouse cardiomyocytes increased H3K36me2 with activation of and repression of target genes in the NAD pathway before dilated cardiomyopathy initiated.
View Article and Find Full Text PDFBMJ Open
March 2022
Department of Civil and Environmental Engineering, Carleton University, Ottawa, Ontario, Canada
Introduction: The complex dynamics of the coronavirus disease 2019 (COVID-19) pandemic has made obtaining reliable long-term forecasts of the disease progression difficult. Simple mechanistic models with deterministic parameters are useful for short-term predictions but have ultimately been unsuccessful in extrapolating the trajectory of the pandemic because of unmodelled dynamics and the unrealistic level of certainty that is assumed in the predictions.
Methods And Analysis: We propose a 22-compartment epidemiological model that includes compartments not previously considered concurrently, to account for the effects of vaccination, asymptomatic individuals, inadequate access to hospital care, post-acute COVID-19 and recovery with long-term health complications.
JCI Insight
December 2018
Department of Biochemistry and Biomedical Sciences.
J Am Coll Cardiol
September 2003
Department of Medicine, University of Ottawa and University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada K1Y 4W7.
Objectives: This study examined the effect of aspirin on the risk of embolic events in infective endocarditis (IE).
Background: Embolism is a major complication of IE, and studies in animal models have shown that platelet inhibition with aspirin can lead to more rapid vegetation resolution and a lower rate of embolic events.
Methods: We conducted a randomized, double-blinded, placebo-controlled trial of aspirin treatment (325 mg/day) for four weeks in patients with IE to test the hypothesis that the addition of aspirin would reduce the incidence of clinical systemic embolic events.